1. Recombinant Proteins: Hopes for Tissue Engineering

Mohammad Morad Farajollahi, Sepideh Hamzehlou, Ahmad Mehdipour, Ali Samadikuchaksaraei*

Bioimpacts. 2012;2(3): 123-125. doi: 10.5681/bi.2012.010

PMCID: PMC3648934 PMID: 23678450 Scopus ID: 84876695772

Article

PDF

XML

Cited By:

Hypothesis

2. Promoters of Cancer Genes for Recombinant Protein Expression in Human Cancer Cell Lines

Mohammad Pourhassan-Moghaddam, Behrouz Farhadi, Kazem Nejati-Koshki*

Bioimpacts. 2012;2(1): 55-60. doi: 10.5681/bi.2012.007

PMCID: PMC3648915 PMID: 23678442 Scopus ID: 84876804823

Article

PDF

XML

Cited By:

Original Article

3. Recombinant receptor-binding motif of spike COVID-19 vaccine candidate induces SARS-CoV-2 neutralizing antibody response

Hossein Samiei-Abianeh , Shahram Nazarian* , Emad Kordbacheh, Alireza Felegary

Bioimpacts. 2025;15: 30520 | Published on: 2024 Nov 04. doi: 10.34172/bi.30520

Article

PDF

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate: 24%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded, Google Scholar; SJR ; Essential Science Indicators; Publons; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO; Ulrich
Member of COPE
Follower of ICMJE
Permission: Creative Commons